KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Total Current Liabilities (2016 - 2026)

Astrazeneca has reported Total Current Liabilities over the past 11 years, most recently at -$32.6 billion for Q1 2026.

  • For Q1 2026, Total Current Liabilities fell 11.81% year-over-year to -$32.6 billion; the TTM value through Mar 2026 reached -$32.6 billion, down 11.81%, while the annual FY2025 figure was -$30.6 billion, 209.87% down from the prior year.
  • Total Current Liabilities for Q1 2026 was -$32.6 billion at Astrazeneca, down from -$30.6 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $30.5 billion in Q4 2023 and troughed at -$34.1 billion in Q3 2025.
  • A 5-year average of -$18.1 billion and a median of -$26.4 billion in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: rose 16.37% in 2022 and later plummeted 209.87% in 2025.
  • Year by year, Total Current Liabilities stood at $26.3 billion in 2022, then grew by 16.16% to $30.5 billion in 2023, then dropped by 8.76% to $27.9 billion in 2024, then plummeted by 209.87% to -$30.6 billion in 2025, then fell by 6.38% to -$32.6 billion in 2026.
  • Business Quant data shows Total Current Liabilities for AZN at -$32.6 billion in Q1 2026, -$30.6 billion in Q4 2025, and -$34.1 billion in Q3 2025.